Verition Fund Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,700
Closed -$2.61M 2688
2025
Q4
$2.61M Sell
25,700
-8,500
-25% -$683K 0.01% 1372
2025
Q3
$1.87M Buy
34,200
+20,000
+141% +$999K 0.01% 2031
2025
Q2
$755K Buy
14,200
+2,600
+22% +$132K ﹤0.01% 2671
2025
Q1
$502K Buy
+11,600
New +$587K ﹤0.01% 2589

Other funds holding EXAS

Verition Fund Management's EXAS Position: Q1 2026 in Review

Verition Fund Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,234,379 shares — an estimated $125M sold.

Verition Fund Management first reported a position in EXAS in Q2 2018 and held it in 22 quarters. The position peaked at $125M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Verition Fund Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 1,234,379 Exact Sciences shares in Q1 2026, an estimated $125M.
  • Verition Fund Management first reported a position in Exact Sciences in Q2 2018 and held it in 22 quarters.
  • Verition Fund Management's Exact Sciences position peaked at $125M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.